Biotech · Private company
TWi Biotechnology, Inc.
Track this companyFree. Adds TWi Biotechnology, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials31 recruiting or active
Pipeline programs5From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline5
- AC-203Phase 3 · Generalized Epidermolysis Bullosa SimplexClinicalTrials.gov · fetched Nov 12, 2026
- VehiclePhase 3 · Generalized Epidermolysis Bullosa SimplexClinicalTrials.gov · fetched Nov 12, 2026
- NORA520 Dose 1Phase 2 · Depression, PostpartumClinicalTrials.gov · fetched Nov 12, 2026
- NORA520 Dose 2Phase 2 · Depression, PostpartumClinicalTrials.gov · fetched Nov 12, 2026
- AC-1101Phase 1 · Granuloma AnnulareClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- An International, Multicenter, Randomized, Double-Blind, Parallel Group, Vehicle-Controlled, Phase 2/3 Study With Open-Label Extension Evaluating the Efficacy and Safety of Diacerein 1% Ointment for the Treatment of Generalized Epidermolysis Bullosa Simplex (EBS)PHASE2_PHASE3 · ACTIVE_NOT_RECRUITING · started Apr 4, 2024ClinicalTrials.gov NCT06073132 · fetched Nov 12, 2026
- A Study to Assess the Efficacy, Safety, and Tolerability of Oral NORA520 in Adults With Severe Postpartum DepressionPHASE2 · COMPLETED · started Mar 28, 2024ClinicalTrials.gov NCT06285916 · fetched Nov 12, 2026
- Study to Evaluate the Safety and Tolerability of AC-1101 Topical Gel in Patients with Granuloma AnnularePHASE1 · COMPLETED · started Oct 3, 2022ClinicalTrials.gov NCT05580042 · fetched Nov 12, 2026